Cargando…
The small molecule Retro-1 enhances the pharmacological actions of antisense and splice switching oligonucleotides
The attainment of strong pharmacological effects with oligonucleotides is hampered by inefficient access of these molecules to their sites of action in the cytosol or nucleus. Attempts to address this problem with lipid or polymeric delivery systems have been only partially successful. Here, we desc...
Autores principales: | Ming, Xin, Carver, Kyle, Fisher, Michael, Noel, Romain, Cintrat, Jean-Christophe, Gillet, Daniel, Barbier, Julien, Cao, Canhong, Bauman, John, Juliano, Rudolph L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3616695/ https://www.ncbi.nlm.nih.gov/pubmed/23396438 http://dx.doi.org/10.1093/nar/gkt066 |
Ejemplares similares
-
Splice-switching antisense oligonucleotides as therapeutic drugs
por: Havens, Mallory A., et al.
Publicado: (2016) -
Retro-1-Oligonucleotide Conjugates. Synthesis and Biological Evaluation
por: Agramunt, Jordi, et al.
Publicado: (2019) -
Hybridization-mediated off-target effects of splice-switching antisense oligonucleotides
por: Scharner, Juergen, et al.
Publicado: (2020) -
Induction of cryptic pre-mRNA splice-switching by antisense oligonucleotides
por: Ham, Kristin A., et al.
Publicado: (2021) -
Antisense Oligonucleotide-Mediated Splice Switching: Potential Therapeutic Approach for Cancer Mitigation
por: Raguraman, Prithi, et al.
Publicado: (2021)